In line with its US pursuit, medical equipment manufacturer Optiscan Imaging (ASX: OIL) has signed a know-how agreement with the…
Over 20,000 Aussies are diagnosed with breast cancer every year and is the most commonly diagnosed cancer among women in…
Would you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah,…
With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in…